Interleukin-6 and interleukin-6 promoter polymorphism (-174) G>C in patients with spontaneous venous thromboembolism

Thrombosis and Haemostasis

Volumn 95, Issue 5, 2006, Pages 802-806

  Vormittag, Rainer ^a   Hsieh, Kety ^a   Kaider, Alexandra ^a   Minar, Erich ^a   Bialonczyk, Christine ^b   Hirschl, Mirko ^c   Mannhalter, Christine ^a   Pabinger Fasching, Ingrid ^a,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Wilhelminenspital Vienna ^*  (Austria)

^c Department of Angiology   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Interleukin 6; Interleukin 6 promoter polymorphism; Pulmonary embolism; Venous thrombosis

Indexed keywords

CYTOSINE; GUANINE; INTERLEUKIN 6;

ADULT; ALLELE; ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL ELECTROPHORESIS; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN POLYMORPHISM; RISK ASSESSMENT; SENSITIVITY ANALYSIS; VENOUS THROMBOEMBOLISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PULMONARY EMBOLISM; RISK; VENOUS THROMBOSIS;

EID: 33646461403     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-12-0816     Document Type: Article

References (35)

1. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol 2001; 115: 3-12.
2. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-76.
3. Reitsma PH, Rosendaal FR. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2004; 2: 619-22.
4. van Aken BE, den Heijer M, Bos GM, et al. Recurrent venous thrombosis and markers of inflammation. Thromb Haemost 2000; 83: 536-9.
5. Salobir B, Sabovic M. Possible vascular-bed-specific role of interleukin-6 in young women with a history of myocardial infarction, lacunar cerebral infarction and deep vein thrombosis. Cytokine 2004; 25: 265-72.
6. Salobir B, Sabovic M. Interleukin-6 and antiphospholipid antibodies in women with contraceptive-related thromboembolic disease. Obstet Gynecol 2004; 104: 564-70.
7. Tsai AW, Cushman M, Rosamond WD, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 2002; 113: 636-42.
8. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
9. Wilkerson WR, Sane DC. Aging and thrombosis. Semin Thromb Hemost 2002; 28: 555-68.
10. Neumann FJ, Ott I, Marx N, et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997; 17: 3399-405.
11. Chin BS, Conway DS, Chung NA, et al. Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis. Blood Coagul Fibrinolysis 2003; 14: 515-21.
12. Amrani DL. Regulation of fibrinogen biosynthesis: glucocorticoid and interleukin-6 control. Blood Coagul Fibrinolysis 1990; 1: 443-6.
13. Ray A. A SAF binding site in the promoter region of human gamma-fibrinogen gene functions as an IL-6 response element. J Immunol 2000; 165: 3411-7.
14. Haidaris PJ. Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. Blood 1997; 89: 873-82.
15. Undar L, Ertugrul C, Altunbas H, et al. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: A possible association with interleukin-6. Thromb Haemost 1999; 81: 571-5.
16. Hooper WC, Phillips DJ, Evatt BL. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor. Thromb Haemost 1997; 77: 1014-9.
17. Stirling D, Hannant WA, Ludlam CA. Transcriptional activation of the factor VIII gene in liver cell lines by interleukin-6. Thromb Haemost 1998; 79: 74-8.
18. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343: 457-62.
19. Tracy RP, Arnold AM, Ettinger W, et al. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 1999; 19: 1776-83.
20. Haring D, Endler G, Hsieh K, et al. Comparison of methods for determination of interleukin 6 G(-174)C promoter polymorphism. Biotechniques 2002; 33: 1114-7.
21. Pabinger I, Grafenhofer H, Kaider A, et al. Pre-eclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol 2001; 21: 874-9.
22. Tsai AW, Cushman M, Rosamond WD, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 2002; 113: 636-42.
23. Vormittag R, Vukovich T, Schonauer V, et al. Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism. Thromb Haemost 2005; 93: 488-93.
24. Jenny NS, Tracy RP, Ogg MS, et al. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 2002; 22: 2066-71.
25. Brull DJ, Leeson CP, Montgomery HE, et al. The effect of the Interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers. Eur J Clin Invest 2002; 32: 153-7.
26. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138-44.
27. Lei SF, Deng FY, Liu XH, et al. Polymorphisms of four bone mineral density candidate genes in Chinese populations and comparison with other populations of different ethnicity. J Bone Miner Metab 2003; 21: 34-42.
28. Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209-14.
29. Acalovschi D, Wiest T, Hartmann M, et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003; 34: 1864-9.
30. Pola R, Flex A, Gaetani E, et al. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 2003; 34: 881-5.
31. Greisenegger S, Endler G, Haering D, et al. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thromb Res 2003; 110: 181-6.
32. Exner M, Schillinger M, Minar E, et al. Interleukin-6 promoter genotype and restenosis after femoro-popliteal balloon angioplasty: initial observations. Radiology 2004; 231: 839-44.
33. Endler G, Marsik C, Joukhadar C, et al. The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin Chem 2004; 50: 195-200.
34. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-8.
35. Stouthard JM, Levi M, Hack CE, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996; 76: 738-42.